The Endocrine Society’s recent virtual Science Writers Conference has signaled a transformative era in the treatment of obesity, transitioning the…
In a strategic move to bolster its leadership in metabolic research and clinical care, NYU Langone Health has named Marcus…
The Molecular Discovery: A New Frontier in Preventive Cardiology The research focuses on subclinical carotid atherosclerosis (SCA), a condition characterized…
The clinical narrative surrounding semaglutide, the blockbuster glucagon-like peptide-1 (GLP-1) receptor agonist, is undergoing a profound transformation. Long shadowed by…
The clinical management of obesity has reached a critical juncture as healthcare providers and professional organizations seek to bridge the…
The observance of American Heart Month in February serves as a critical juncture for the medical community to evaluate the…
The United States Congress has finalized a comprehensive funding bill for the Department of Health and Human Services (HHS) for…
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally developed to manage type 2 diabetes, have undergone a rapid evolution in clinical…
The landscape of metabolic medicine has undergone a seismic shift with the introduction and rapid adoption of glucagon-like peptide-1 receptor…
The Endocrine Society has unveiled a comprehensive strategic framework designed to fortify the global endocrine research community, centering its efforts…
Amara Maple